{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:14:33Z","timestamp":1761920073234},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/nrl.0000000000000057","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T15:16:02Z","timestamp":1444922162000},"page":"61-66","source":"Crossref","is-referenced-by-count":11,"title":["Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort"],"prefix":"10.1097","volume":"20","author":[{"given":"Ayse","family":"Altintas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Karabudak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belgin P.","family":"Balci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysun","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahattin","family":"Saip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli","family":"Tuncer Kurne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Uygunoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mecbure","family":"Nalbantoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokcen","family":"Gozubatik Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihal","family":"Isik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahya","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"Gokcay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taskin","family":"Duman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cavit","family":"Boz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Yucesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Serhat","family":"Mangan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nese","family":"Celebisoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevda","family":"Diker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilksen","family":"Colpak Isikay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulay","family":"Kansu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aksel","family":"Siva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210211","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":". The clinical course of neuromyelitis optica (Devics syndrome).","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"R2-2-20210211","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":". A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet Neurol"},{"key":"R3-2-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","article-title":". Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain.","volume":"17","author":"Nielsen","year":"1997","journal-title":"J Neurosci"},{"key":"R4-2-20210211","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuroscience.2004.03.016","article-title":". Expression of aquaporin water channels in mouse spinal cord.","volume":"127","author":"Oshio","year":"2004","journal-title":"Neuroscience"},{"key":"R5-2-20210211","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrn1252","article-title":"The molecular basis of water transport in the brain.","volume":"4","author":"Amiry-Moghaddam","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"R6-2-20210211","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":". Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"R7-2-20210211","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","article-title":". A secondary progressive clinical course is uncommon in neuromyelitis optica.","volume":"68","author":"Wingerchuk","year":"2007","journal-title":"Neurology"},{"key":"R8-2-20210211","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival.","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology"},{"key":"R9-2-20210211","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":". The spectrum of neuromyelitis optica.","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"R10-2-20210211","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":". A role for humoral mechanisms in the pathogenesis of Devics neuromyelitis optica.","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"R11-2-20210211","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","article-title":". Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.","volume":"125","author":"Misu","year":"2013","journal-title":"Acta Neuropathol"},{"key":"R12-2-20210211","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":". Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"R13-2-20210211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","article-title":". Clinical characteristics, course and prognosis of relapsing Devics neuromyelitis optica.","volume":"251","author":"Ghezzi","year":"2004","journal-title":"J Neurol"},{"key":"R14-2-20210211","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458513515085","article-title":". Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.","volume":"20","author":"Collongues","year":"2013","journal-title":"Mult Scler"},{"key":"R15-2-20210211","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":". Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients.","volume":"9","author":"Jarius","year":"2012","journal-title":"Neuroinflammation"},{"key":"R16-2-20210211","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2012.06.002","article-title":". Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.","volume":"320","author":"Jarius","year":"2012","journal-title":"J Neurol Sci"},{"key":"R17-2-20210211","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/1352458511424590","article-title":". Quantitative measurement of anti-aquaporin- 4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.","volume":"18","author":"Kim","year":"2012","journal-title":"Mult Scler"},{"key":"R18-2-20210211","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":". Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"key":"R19-2-20210211","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00415-010-5780-4","article-title":". Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.","volume":"258","author":"Akman-Demir","year":"2011","journal-title":"J Neurol"},{"key":"R21-2-20210211","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2009.04.014","article-title":". The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.","volume":"212","author":"Idiman","year":"2009","journal-title":"J Neuroimmunol"},{"key":"R22-2-20210211","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":". Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.","volume":"306","author":"Jarius","year":"2011","journal-title":"J Neurol Sci"},{"key":"R23-2-20210211","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1352458508101935","article-title":". Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.","volume":"15","author":"Bichuetti","year":"2009","journal-title":"Mult Scler"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/NRL.0000000000000057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:38:38Z","timestamp":1620967118000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-201510000-00002"}},"subtitle":["Demographic, Clinical, and Laboratory Features"],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0000000000000057","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}